chrisvoncsefalvay/vaers-outcomes huggingface dataset:
about 10 hours after receiving the vaccine experienced extreme malasia, including sensitive skin, migrane, night sweats for 2 nights.  Also have redness/ swelling/ itching on injection site that appeared after about 36 hours,  4 inches in diameter
she is a little sore; swollen lymph nodes in her neck and shoulder; This is a spontaneous report from a contactable consumer (patient). A 59-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date as a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient's historical vaccine included first dose of BNT162B2 (COVID Pfizer vaccine) on an unspecified date for covid-19 immunization. The patient stated that she was a little sore and experienced swollen lymph node in her neck and shoulder on an unspecified date. She wanted to know how long does the side effects last. She asked if the events did not go away in 10 days then what should she do and can she take anything for them.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Exposed to the COVID; This is a spontaneous report received from a contactable reporter(s) (Other HCP) for a Pfizer sponsored program. The reporter is the parent.  A 64 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "Stents" (not ongoing), notes: he has a couple of stents. The patient's concomitant medications were not reported. The following information was reported: EXPOSURE TO SARS-COV-2 (non-serious), outcome "unknown", described as "Exposed to the COVID".   The lot number for bnt162b2 was not provided and will be requested during follow up.
My husband a 51 years old male,healthy died after Pfizer vaccine 4; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 51-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 1, manufacturer unknown), for COVID-19 immunization; Covid-19 vaccine (DOSE 2, manufacturer unknown), for COVID-19 immunization; Covid-19 vaccine (DOSE 3, manufacturer unknown), for COVID-19 immunization. The following information was reported: DEATH (death), outcome "fatal", described as "My husband a 51 years old male,healthy died after Pfizer vaccine 4". The date and cause of death for the patient were unknown. It was not reported if an autopsy was performed. The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.; Reported Cause(s) of Death: My husband a 51 years old male,healthy died after Pfizer vaccine 4
Sometime following the vax, the pt experienced a rash. The pt reportedly recovered from this experience
Shingles covered left side of forehead, eye, and nose; Shingles covered left side of forehead, eye, and nose; This is a spontaneous report from a contactable consumer (patient). A 38-years-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), dose 2 via an unspecified route of administration, administered in right arm on 09Apr2021 16:00 (Batch/Lot Number: ER8729) as a single dose (at the age of 38 years old) for COVID-19 immunisation.  Medical history included overactive bladder. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medication(s) included oxybutynin (OXYBUTYNIN) taken for an unspecified indication, start and stop date were not reported. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously received dose 1 of BNT162b2 (at the age of 38 years old) on 19Mar2021 at 4:00 PM (batch/lot number: ER8727) in Right arm. On 23Apr2021, at 06:00 PM, the patient broke out into shingles. Shingles covered left side of forehead, eye, and nose. The event resulted in an Emergency room/department or urgent care visit and the patient received treatment with antiviral medication. The events were reported as non-serious by the patient. The patient was recovering from the shingles. Since the vaccination, has the patient has not been tested for COVID-19.
Initial unsolicited report received from a consumer via other company (Pfizer) on 17 August 2016. Manufacturer Report Number: 2016380448. This case involves a female patient (age not reported) who was vaccinated with a dose of DIPHTHERIA AND TETANUS TOXOIDS (DT) (manufacturer: unknown, batch number, expiry date, dose, dose in series, route and site of administration were not reported) on an unknown date. The patient's medical history and Concomitant medications were not reported. On an unknown date, following the vaccination, the patient had rare reaction. The patient's laboratory data and corrective treatment was not reported. The outcome of event was not reported. List of documents held by sender: none.
After 55 hours I got chills, a fever, severe vomiting for about an hour.; After 55 hours I got chills, a fever, severe vomiting for about an hour.; After 55 hours I got chills, a fever, severe vomiting for about an hour.; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 12May2021 at 13:30 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history included appendectomy 8 years ago. The patient had no known allergies to medications, food, or other products. The patient did not receive any medication within two weeks of vaccination. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 16Apr2021 at 12:00 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14May2021 at 23:00, after 55 hours the patient got chills, a fever, severe vomiting for about an hour. The patient could not think of any other reason this would have happened so she wanted to tell because it seemed long after the shot. The patient felt perfectly fine until then. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events after 55 hours the patient got chills, a fever, severe vomiting for about an hour was resolving at the time of report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
no additional AE reported; inadvertently received a 3rd dose of VAQTA; This spontaneous report was received from a licensed practical nurse (LPN) and refers to a patient of unknown age and gender. No information regarding the patient's medical history, concurrent conditions, drug reactions or allergies and concomitant medications was provided.  On an unknown date in September 2019, the patient was vaccinated with the first dose of hepatitis a vaccine, inactivated (VAQTA) prefilled syringe, lot # T017179 was confirmed to be valid, expiration date was 26-OCT-2021, 1 ml (route of administration and anatomical location were not reported) for prophylaxis. On an unknown date in November 2020, the patient was vaccinated with the second dose of hepatitis a vaccine, inactivated (VAQTA). On 20-JAN-2021 (also reported as two weeks ago), the patient was inadvertently vaccinated with the third dose of hepatitis a vaccine, inactivated (VAQTA) (inappropriate schedule of product administration). No additional adverse events was reported. combinationproductreport: Yes; brandname: VAQTA SYRINGE (DEVICE); commondevicename: Hepatitis A Vaccine, Inactivated; productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp. devicelotnumber: T017179; expirationdate: 26-OCT-2021; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability
The same day of the vaccine, I developed a very sore arm, lifting my arm hurt more than when it was just down at my side. The site was a bit red. That soreness lasted a good 3-4 days. On Day 8, I woke up with mild soreness in my arm and a huge red rash around the injection site.
The day after I received the 2 Pfizer Covid 19 vaccination I had terrible pains on my right side right below my shoulder blade.  This lasted for 2 weeks.  It was excruciating.  Then it went away but in October 2021 it was back, same spot, same pain and it would not go away.  After going to my primary doctor, he did a x-ray of my back and found a gray mass that was attached to my rib cage.  From there he sent be to for further test.
Unclear if the adverse event is related to vaccination at all, but beginning a few weeks after my second dose on 5/15/21, I started getting what I thought were heart palpitations periodically. Initial hospital visit found no heart damage, and primary care follow up resulted in likely GERD diagnosis. Several more instances of heart palpitation feeling, but after return trip to urgent care several months later, they confirmed Afib that subsided after 20 minutes.  Wore halter monitor, had echocardiogram and several EKG over ensuing weeks, with no further instances of afib. I have changed my diet to reduce red mearlt consumption, reduced already low alcohol consumption, and focused on better hydration which may be staving off additional afib episodes.
This spontaneous report was received from a healthcare worker refers to a male patient of approximately 15 years of age. The patient's concurrent medical condition included allergy to wasp venom and allergy to EPIPEN. On 08-FEB-2014, the patient was vaccinated with GARDASIL dose 1 (strength, route of administration and lot number were not reported). There was no concomitant medication. On an unknown date in 2014 the patient got sick and the patient canceled his appointment to receive his second dose of GARDASIL. The patient experienced fever and sore throat and was treated with penicillin on 17-APR-2014. The reporter was unsure when exactly the symptoms of the patient had started. There were no lab diagnostic studies performed. The patient had sought medical attention. There was no product quality complaint (PQC) involved. It was reported that the patient had recovered from the event on an unknown date in 2014. The causality of the events was not provided. Additional information has been requested.
about 6 weeks after 2n dose.(1st dose red swollen painful arm about 10 days after and lasted about 10 days. 2nd shot reaction about 6 weeks after,  Painful red swollen arm in bed 24+ hrs exhausted, unable to get out of bed. Legs started to swell bilaterally 3+ pitting edema to mid calf and become very fatigued. Unable to do stairs as DOE faculations of muscles arms, legs,eyes appetite deminished
syncope; seizure; Tremors; heart pauses; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 37-year-old male patient received BNT162b2 (BNT162B2), on 14Sep2021 at 15:45 as dose 2, single (Lot number: Ew0172) at the age of 37 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "TBI" (unspecified if ongoing); "migraines" (unspecified if ongoing); "insomnia" (unspecified if ongoing); "high cholesterol" (unspecified if ongoing); "depression" (unspecified if ongoing); "anxiety" (unspecified if ongoing); "syncope" (unspecified if ongoing). There were no concomitant medications. Past drug history included: Codeine, reaction(s): "Known allergies"; Gluten, reaction(s): "Known allergies". Vaccination history included: BNT162b2 (Dose 1, single, dose lot number=Ew0172, dose administration time: 03:45 PM,, dose vaccine location: Right arm), administration date: 24Aug2021, when the patient was 36-year-old, for COVID-19 immunization. The following information was reported: TREMOR (life threatening) with onset 15Sep2021 at 08:00, outcome "not recovered", described as "Tremors"; CARDIAC DISORDER (life threatening) with onset 15Sep2021 at 08:00, outcome "not recovered", described as "heart pauses"; SEIZURE (medically significant, life threatening) with onset 15Sep2021 at 08:00, outcome "not recovered"; SYNCOPE (medically significant, life threatening) with onset 15Sep2021 at 08:00, outcome "not recovered". The events "syncope", "seizure", "tremors" and "heart pauses" required physician office visit and emergency room visit. Therapeutic measures were taken as a result of syncope, seizure, tremor, cardiac disorder.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300205478 same reporter/patient/vaccine, different dose/event;
Information has been received from a nurse practitioner via a company representative referring to a 15 years old female patient. Pertinent medical history and drug reactions/allergies were not reported. The patient received the first dose in the series of three of GARDASIL (0.5 ml, intramuscularly, lot# and expiration date were not reported) on an unspecified date in July 2015 and received a second dose on an unspecified date in October 2015 and then the third dose 1 month later, on an unspecified date in November 2015 (inappropriate schedule of drug administration). Concomitant drug was not reported. No adverse effects were reported. Additional information has been requested.
Within 48 hours of receiving the second Covid shot, I woke up with vertigo and sudden hearing loss and ringing/buzzing in my left ear.  I was taken to urgent care and prescribed nausea medication and Dramamine.  I made an appointment with an ENT doctor who prescribed steroids.  I finished taking the steroids 3 days ago and I still have vertigo and hearing loss and ringing/buzzing in my ear.  This has been going on for coming up on 3 weeks now.
She was vaccinated on 3/25 here at clinic with moderna (right arm) and had a fever that night, then the next day had hives on her neck with itching, then another elevated temp the third day, then on the 4th day she had pain in both arms and right axilla followed by petechiae that has spread down the right arm and some on the left; she says the petechiae is just now resolving.
Covid arm; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0153) via an unspecified route of administration in the left arm on 09Jul2021 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient previously took cefalexin (KEFLEX) on an unknown date for an unknown indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 15Jun2021 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On an unknown date in Jul2021 the patient experienced COVID arm. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the event COVID arm was unknown at the time of this report.
Patient complains of intense pain going down her left arm inhibiting her from using her arm in any capacity.
Occurring 1 day after vaccine  was Pain, redness, swelling, warm to the touch, itching at the injection site. Underarm nodes swollen and painful when lifting arm above head.  Symptoms is still present on 3/14/2021. Vitual Drs visit, prescribed Prednisone and icing the affect area
SUSPECTED CLINICAL VACCINATION FAILURE; SUSPECTED COVID-19 INFECTION; This spontaneous report received from a patient concerned a 22 year old Asian male of unknown ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808978 expiry: 11-SEP-2021) 1 total, administered on 07-JUN-2021 for prophylactic vaccination (Dose number in series 1). No concomitant medications were reported.  On an unspecified date, the patient was exposed in the household and had symptoms of covid including runny nose, cough and a headache (suspected covid-19 infection and suspected clinical vaccination failure). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the suspected covid-19 infection and suspected clinical vaccination failure was not reported. This report was serious (Other Medically Important Condition). This report is associated with regularity authority: 90000210990.; Sender's Comments: V0: 20220109975-covid-19 vaccine ad26.cov2.s- Suspected clinical Vaccination failure. This event is considered not related. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event than the drug. Specifically: SPECIAL SITUATIONS
Patient has developed migraines and also had lower extremity weakness. When she got influenza A she developed left deviation of the tongue and had temporary cogwheeling in the left leg
Patient began very heavy menstrual cycle, 2 weeks earlier than expected, 6 days after receiving second Pfizer COVID-19 vaccine.  She is bleeding through maxi pads every 15-30 minutes, passing smaller than quarter-sized clots, with associated severe menstrual cramping, when she previously had no history of this.
Patient was under age when she received covid 19 moderna dose 1. Parents want patient to get dose 2
Initial injection, Dec 23rd,  I had burning sensation for 3-5 minutes at which time it subsided. Approx 3 hrs later my arm was achy, stiff ( especially went not moving) and sore for 3days or so. On Jan 1, I noticed a large red, warm area on my deltoid in the area of injection site. At this point arm is feeling a bit sore
I don't know the answer to the questions about the vaccine (e.g. specific vaccine type, manufacturer). I received a flu shot in my left arm.  I think I had a reaction to the flu shot. I had a flu shot around 9:30am on 11/22/2021. I had pain in my arm after getting the shot. And also noticed bruising around the site of the injection. When I woke up the next morning (11/23/2021), the lower half of my face and my neck were covered in hives. My face and neck were splotchy, swollen and red. I've since taken an antihistamine and the symptoms have lessened. But it is now 11/24/2021 and I can still feel the allergic reaction - my face still has hives (but they are milder) and my nasal passage feels narrow/swollen (but I can still breathe)
Feel tired, chill, mild fever(100.9F), Whole body ache(muscle, bone, nerve pain) with headache, Sense of smell and taste lower down, tonsil swelling,  Lymph node swelling and pain.
Patient states, BM in bed x 2, not able to walk. Started PM at vaccination. Had fever, (no measurement given). Arm was swollen and had no strength in his legs. Returned to normal by 11/3/14.
Headache; Chills; Sweatiness; Body aches; Dizziness; Nausea; Eye pain; Anxiety; Racing heart; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 32030BD) via an unspecified route of administration in the left arm on 31Oct2021 at 14:45 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included diabetes and mast cell activation syndrome (MCAS) and the patient was allergic to eggs. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included cetirizine hydrochloride (ZYRTEC), lisinopril (MANUFACTURER UNKNOWN), metformin (MANUFACTURER UNKNOWN) and acetylsalicylic acid (ASPIRIN), all taken for unknown indications from an unknown date and unknown if ongoing. The patient previously received influenza vaccine (flu vaccine) (MANUFACTURER UNKNOWN) for immunisation and experienced allergy to vaccine. On 31Oct2021 at 14:45, the patient experienced headache, chills, sweatiness, body aches, dizziness, nausea, eye pain, anxiety and racing heart. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, chills, sweatiness, body aches, dizziness, nausea, eye pain, anxiety and racing heart were not resolved at the time of this report.
Initial report was received on 07 and 16 February 2011 from a health care professional. This case is one of a cluster of two identified patients who experienced similar adverse events following administration of DAPTACEL. The events for the other patient were captured in case 2011-00550. A four year-old patient with no reported past medical history and no illness at the time of vaccination had received a fourth dose right arm injection of DAPTACEL, lot number C3515AA (route of administration not reported) and a fourth dose right arm injection of IPOL (lot number and route of administration not reported) on 04 February 2011 and an unspecified amount of time later, experienced swelling, redness, warmth and itching of the entire arm (also reported as the upper arm toward the elbow). The patient was also reported to have "whined all night". The patient was evaluated by a physician. Treatments were not reported. No further information was available at the time of the report. The patient's outcome was unknown. Follow-up information was received from the health care professional on 12 April 2011. The patient had not received any other vaccines within 4 weeks of 04 February 2011, was not taking any concomitant medications, and was not ill at the time of vaccination. The outcome was reported as recovered. No additional information was provided. Follow-up information was received 29 April 2011 from a health care professional. IPOL, lot number E0204, had been administered in the right deltoid. No additional information was provided. Documents held by sender: none.
Presented with SOB; Covid positive.  Dx:  Covid 19 pneumonia and acute respiratory failure and also  chronic systolic heart failure exacerbation.  TX: IV diuretics, steroids was initiated on remdesevir.  He was quickly weaned off oxygen and his symptomatology was very mild in terms of Covid so remdesevir was discontinued and patient was discharged home ID in fact recommended no discharge steroids.  Patient was sent home on supportive treatments.
Severe reaction resulting in 911 call and paramedic transport to hospital. Numbness, racing heart, shortness of breath, itching.